B-cell receptor pathway inhibitors affect CD20 levels and impair antitumor activity of anti-CD20 monoclonal antibodies

Affiliations

• ¹ Department of Immunology, Center for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
• ² Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
• ³ International Centre for Genetic Engineering and Biotechnology, Molecular Hematology Group, Campus A. Buzzati-Traverso, Rome, Italy.
• ⁴ IBiSA Cancer Immunomonitoring Platform, Institut Paoli Calmettes, UM 105, Aix-Marseille Université, Marseille, France.
• ⁵ 1] Department of Immunology, Center for Biostructure Research, Medical University of Warsaw, Warsaw, Poland [2] Department 3, Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland.